Iovance Biotherapeutics (IOVA) announced that Dan Kirby will join the Company’s executive leadership team in the newly created role of Chief Commercial Officer, effective today. Prior to joining Iovance, Kirby led global commercial strategy for an emerging cell therapy platform of products as Chief Commercial Officer of Orca Bio.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA: